Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
36.52
1.45 (4.13%)
At close: Aug 21, 2025, 11:30 AM

Caris Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q2 2024 Q1 2024 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Jun 30, 2024 Mar 31, 2024 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-71.79M -102.58M -66.19M -111.03M 51.16M 37.94M 35.74M
Depreciation & Amortization
6.41M 7.04M 11.61M 17.7M 32.88M 29.48M 28.77M
Stock-Based Compensation
28.29M 14.69M 4.49M 4.46M 566K 593K 540K
Other Working Capital
-25.7M 5.09M 1.53M -52K 1.13M 30.85M 33.65M
Other Non-Cash Items
45.81M 36.19M -8.72M 16.12M -12.99M -7.44M -22.45M
Deferred Income Tax
n/a n/a n/a n/a 4.41M -2.27M -940K
Change in Working Capital
-1.44M 13.32M -4.12M -1.18M 21.6M 27.97M 34.13M
Operating Cash Flow
7.29M -31.34M -62.93M -73.92M 97.61M 86.28M 75.79M
Capital Expenditures
-1.39M -2.69M -2.59M -1.74M -545.17M -105.08M -171.65M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a 61.38M n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a 29.82M 21.62M 27.54M
Investing Cash Flow
-1.39M -2.69M -2.59M 59.64M -515.36M -83.46M -144.11M
Debt Repayment
23.84M -22K -30K 199.9M n/a n/a n/a
Common Stock Repurchased
n/a -22K n/a n/a n/a n/a -12.79M
Dividend Paid
n/a n/a n/a n/a -7.41M -7.41M -7.4M
Other Financial Acitivies
129.1M 1.33M -99K 210K 436.22M -4.66M 69.82M
Financial Cash Flow
681.4M 1.28M -129K 200.11M 428.81M -12.06M 62.42M
Net Cash Flow
687.4M -32.74M -65.63M 185.82M 11.08M -9.37M -5.9M
Free Cash Flow
5.9M -34.03M -65.51M -75.66M -447.56M -18.8M -95.86M